Plunkett Research Online: Aptose Biosciences Inc

APTOSE BIOSCIENCES INC (APTO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aptose Biosciences, Inc. is a clinical stage biotechnology company focused on therapies addressing unmet medical needs in oncology. Aptose researches and develops new therapeutics and molecular diagnostics. Its product pipeline includes cancer drug candidates that exert portent activity as stand-a.....



Aptose Biosciences Inc
Ticker: APTO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647-479-9828
Fax: 905-234-2120
Address: 251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Cancer
Antisense Compounds
Low-Molecular-Weight Compounds
Contacts Description

William Rice CEO/Chairman of the Board/Director/President
Gregory Chow CFO/Chief Accounting Officer/Senior VP
See More
Aptose Biosciences, Inc. is a clinical stage biotechnology company focused on therapies addressing unmet medical needs in oncology. Aptose researches and develops new therapeutics and molecular diagnostics. Its product pipeline includes cancer drug candidates that exert portent activity as stand-a.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
CG-806
APTO-253
APL-581
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: